Apalutamide 60 mg Tablets
Introduction
International pharmaceutical procurement requires dependable suppliers, accurate product specifications, appropriate quality documentation, and compliance with destination-country regulations. These requirements are particularly important when sourcing prescription oncology medicines for hospitals, pharmacies, pharmaceutical distributors, and authorized healthcare organizations.
Apalutamide 60 mg tablets are an oral targeted anticancer medicine used in the treatment of certain forms of prostate cancer. International buyers considering apalutamide from India should evaluate the actual manufacturer, product presentation, quality documents, storage requirements, commercial terms, and eligibility for import into their destination market.
India has an established pharmaceutical manufacturing industry, with companies producing and supplying finished pharmaceutical formulations for domestic and international markets. However, the availability of a particular medicine, brand, or manufacturer must be confirmed before an order is placed.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, provides a contact point for international pharmaceutical sourcing enquiries. Buyers interested in apalutamide 60 mg tablets can enquire about potential sourcing options, subject to confirmation of the requested product, current availability, manufacturer details, and applicable export requirements.
This guide explains the important considerations for sourcing apalutamide 60 mg tablets from India, with a focus on quality verification, pharmaceutical documentation, regulatory compliance, and international supply planning.
Key Highlights
- Generic name: Apalutamide.
- Strength: 60 mg per tablet.
- Dosage form: Oral film-coated tablet.
- Therapeutic category: Targeted oncology medicine; androgen receptor inhibitor.
- Primary treatment area: Certain forms of prostate cancer, according to applicable product labeling.
- Product verification: Confirm brand, manufacturer, pack size, and current availability.
- Quality documentation: Request applicable product specifications, batch records, and quality certificates.
- Storage: Follow the exact manufacturer's approved product labeling.
- Export compliance: Verify destination-market registration, import permits, and importer authorization.
- Buyer support: Dolphin Pharmaceuticals can be contacted to discuss product-specific sourcing requirements.
Understanding Apalutamide 60 mg Tablets
Apalutamide is an androgen receptor inhibitor. It works by blocking androgen receptor signaling, which can contribute to the growth of certain prostate cancer cells.
The medicine is used for specified prostate cancer indications under applicable product labeling. The exact indication depends on the approved product information and the destination country's regulatory authorization.
For pharmaceutical procurement teams, understanding the product's identity and presentation is essential when requesting quotations or comparing suppliers.
Product Details
- Generic name: Apalutamide.
- Common brand reference: Erleada; generic products may be available under different brand names in certain markets.
- Strength: 60 mg per tablet.
- Dosage form: Film-coated tablet.
- Route of administration: Oral.
- Therapeutic category: Oncology medicine; androgen receptor inhibitor.
- Treatment area: Certain forms of prostate cancer, according to the applicable product label.
- Packaging: Pack size and configuration depend on the manufacturer and product.
- Storage: Follow the current approved instructions for the exact product.
- Manufacturer: Must be verified for the specific brand or generic presentation.
- Availability: Confirm directly with the proposed supplier.
- Export eligibility: Depends on the product, applicable regulations, and destination-market authorization.
These details provide a general procurement overview. Buyers should verify the exact product specification, manufacturer, packaging, and approved labeling before proceeding.
Why Quality Matters When Exporting Apalutamide from India
Quality assurance is a central consideration in oncology medicine procurement. Buyers need confidence that the product offered matches the requested specifications and is supported by appropriate documentation.
1. Product Identity and Authenticity
The first step is confirming that the medicine matches the requested product.
Buyers should verify:
- Generic name and strength.
- Brand name, where applicable.
- Dosage form.
- Manufacturer and manufacturing site.
- Pack size and packaging configuration.
- Batch number and expiry date.
- Product labeling and supporting documentation.
These details help prevent confusion between products with similar names or different presentations.
2. Manufacturer Transparency
A pharmaceutical exporter may manufacture a medicine directly, distribute products made by another company, or arrange sourcing through a third-party manufacturer.
Buyers should establish the supplier's role and identify the actual manufacturer of the offered apalutamide product.
Manufacturer details should be consistent across the product label, quotation, and supporting documentation. Any discrepancy should be clarified before an order is confirmed.
3. Product and Batch Documentation
Appropriate documentation supports product verification and procurement review.
Depending on the medicine and destination-market requirements, buyers may request:
- Product specifications.
- Manufacturer information.
- Batch details and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product registration or approval records, where required.
- Traceability documentation, where applicable.
The exact documentation package should be agreed upon before shipment.
4. Packaging and Product Integrity
Packaging helps protect medicines during storage and transportation. Buyers should verify that the proposed packaging corresponds to the approved product presentation and remains intact throughout the supply chain.
The receiving organization should have procedures for checking packaging condition, product identity, batch details, and expiry information when the shipment arrives.
5. Shelf-Life Management
Remaining shelf life is an important consideration in international pharmaceutical procurement. Transit time, customs clearance, and local distribution can reduce the time available for further supply.
Buyers should specify any minimum remaining shelf-life requirement before accepting a quotation and confirm the expiry details before dispatch.
Dolphin Pharmaceuticals: Pharmaceutical Sourcing from India
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, provides an enquiry channel for international pharmaceutical buyers seeking sourcing information.
For buyers interested in apalutamide 60 mg tablets, the company can be approached to determine whether the requested product can be supplied or sourced through its current arrangements.
The presence of oncology products in a supplier's broader catalogue does not automatically establish that apalutamide is available, that the company manufactures it, or that the product is eligible for export to every destination.
Buyers should request written confirmation of:
- Current product availability.
- Generic name and strength.
- Brand and manufacturer details.
- Manufacturing site, where applicable.
- Pack size and minimum order quantity, if applicable.
- Available quality and batch documentation.
- Remaining shelf life.
- Storage and transportation requirements.
- Destination-market export eligibility.
- Quotation, payment terms, and lead time.
This product-specific approach helps buyers evaluate the proposed supply arrangement before making a commercial commitment.
How to Evaluate an Apalutamide Exporter from India
Selecting an exporter requires a structured assessment of supplier credentials, product details, documentation, and commercial terms.
Step 1: Define the Required Product
Prepare a clear specification before contacting potential suppliers.
Include the following information:
- Generic name: apalutamide.
- Strength: 60 mg tablets.
- Preferred brand, if applicable.
- Manufacturer preference, where relevant.
- Required pack size.
- Order quantity.
- Destination country.
- Required product and regulatory documents.
Clear specifications help suppliers assess the enquiry and reduce the risk of product mismatches.
Step 2: Verify Supplier Credentials
Review the supplier's business identity, relevant licences, and role in the pharmaceutical supply chain.
Where required, verify that the manufacturer, exporter, and importing organization have the appropriate authorizations for the proposed transaction.
Do not rely solely on a product listing or marketing statement as proof of current availability, manufacturing status, or destination-market approval.
Step 3: Request Supporting Documentation
Ask for the documents required for your procurement and regulatory review.
Confirm that the product name, strength, manufacturer, batch details, expiry information, and other relevant particulars are consistent across the documents.
Any missing information should be clarified before the shipment is approved.
Step 4: Review Storage and Handling Requirements
Obtain the manufacturer's current storage and handling instructions for the exact product.
For example, the U.S. prescribing information for Erleada 60 mg specifies storage at 20°C to 25°C, with permitted excursions from 15°C to 30°C, and protection from light and moisture in the original package. These conditions should not automatically be applied to another manufacturer's product without checking its own approved labeling.
Buyers should confirm the applicable conditions for the product being sourced and communicate them to the logistics provider and receiving organization.
Step 5: Compare Commercial Terms
Evaluate supplier quotations using the same product specifications and delivery assumptions.
Consider:
- Unit price and order quantity.
- Packaging and minimum order requirements.
- Documentation and certification costs, where applicable.
- Payment terms and quotation validity.
- Shipping and insurance costs, where applicable.
- Expected dispatch and delivery timeline.
- Remaining shelf life.
- Responsibility for export and import procedures.
Price should be assessed alongside product quality, documentation, and regulatory compliance.
Step 6: Confirm Destination-Market Eligibility
Before placing an order, verify whether the specific apalutamide product is registered or otherwise authorized in the destination market.
Confirm whether import permits, importer licences, additional approvals, or specific labeling requirements apply. Complete the relevant checks before dispatch.
Documentation Required for Apalutamide Export
The documentation required for an international pharmaceutical shipment depends on the product, transaction, and destination country's regulations.
Product and Quality Documents
Buyers may need:
- Product specifications.
- Manufacturer and manufacturing-site details.
- Batch number and expiry information.
- Certificate of Analysis, where applicable.
- Relevant manufacturing or quality certificates.
- Product labeling and packaging information.
- Registration or approval documents, where required.
Commercial Documents
Depending on the transaction, these may include:
- Proforma invoice.
- Commercial invoice.
- Packing list.
- Purchase order and agreed commercial terms.
- Applicable shipping documentation.
Regulatory Documents
Depending on the destination market, buyers may need:
- Import permit or other applicable authorization.
- Product registration or approval evidence.
- Certificates required by the relevant authorities.
- Supporting documents for customs clearance.
Not every document applies to every shipment. Buyers should obtain a product-specific checklist from the relevant authorities and qualified regulatory or logistics partners.
Pharmaceutical Export and Import Compliance
International pharmaceutical supply involves requirements that can differ between exporting and importing countries.
For apalutamide 60 mg tablets, buyers should confirm:
- Whether the product is registered or otherwise authorized in the destination country.
- Whether the importing organization holds the required licences.
- Whether an import permit or additional authorization is needed.
- Which manufacturer, product, and quality documents must be submitted.
- Whether labeling and packaging comply with local requirements.
- Which export, shipping, and customs documents are necessary.
The exporter should clarify which documents it can provide. The importer should verify the destination-market requirements with the relevant authorities before the order is finalized.
Important: Availability in India does not automatically mean a medicine is approved for import, distribution, or sale in another country.
Storage, Transportation, and Supply Planning
Appropriate storage and transportation help maintain product integrity throughout the supply chain.
Before dispatch, buyers should confirm:
- The approved storage temperature for the exact product.
- Protection from light and moisture, where required.
- Original packaging and desiccant requirements, where applicable.
- Batch and expiry information.
- Minimum remaining shelf life required on arrival.
- Shipping method and expected transit time.
- Packaging integrity during transport.
- Procedures for handling damaged or non-conforming products.
The exporter, logistics provider, and importer should agree on shipment responsibilities before dispatch.
For recurring procurement, buyers should also plan expected demand, lead times, stock requirements, and documentation review processes to support a more organized supply chain.
Common Challenges When Sourcing Apalutamide
International buyers may encounter several challenges when sourcing oncology medicines across borders.
Unconfirmed Product Availability
A catalogue listing does not guarantee current stock. Obtain written confirmation of availability, quantity, and lead time before making procurement commitments.
Unclear Manufacturer Details
If the actual manufacturer is not identified, request clarification before proceeding. Manufacturer transparency supports product verification and regulatory review.
Incomplete Documentation
Missing or inconsistent documents can delay internal approvals, import processing, or customs clearance. Establish the documentation requirements early.
Differences Between Brands and Presentations
Products containing the same active ingredient may differ in brand, packaging, labeling, and market authorization. Verify the exact product requested by the buyer.
Unclear Commercial Responsibilities
International shipments may involve separate responsibilities for export documentation, import permits, freight, customs clearance, and local delivery. Confirm these responsibilities in writing.
How to Request a Quotation from Dolphin Pharmaceuticals
International pharmaceutical buyers can prepare a detailed enquiry to help Dolphin Pharmaceuticals assess their requirements.
Include the following information:
- Product: Apalutamide 60 mg tablets.
- Preferred brand: If applicable.
- Manufacturer preference: If applicable.
- Required quantity: Specify the expected order volume.
- Pack size: State the required presentation.
- Destination country: Identify the intended import market.
- Documentation: List any required product and quality documents.
- Delivery expectations: Include the preferred shipment timeline.
- Regulatory requirements: Share any known product registration or import conditions.
Ask the company to confirm whether the product can be supplied or sourced, identify the actual manufacturer, provide available documentation, and clarify export eligibility.
Before confirming the purchase, verify the product details, quotation validity, payment terms, shipping arrangements, and applicable regulatory requirements.
Frequently Asked Questions
1. What is apalutamide 60 mg used for?
Apalutamide is an androgen receptor inhibitor used in the treatment of certain forms of prostate cancer. The precise approved indications depend on the applicable product labeling and destination-market authorization.
2. What is the dosage form of apalutamide 60 mg?
The 60 mg presentation is an oral film-coated tablet. Buyers should verify the product's packaging and manufacturer details before placing an order.
3. How can I choose a reliable apalutamide exporter from India?
Evaluate the supplier's business credentials, manufacturer transparency, product documentation, regulatory compliance, commercial terms, and ability to coordinate the proposed shipment.
4. Does Dolphin Pharmaceuticals currently supply apalutamide 60 mg tablets?
Current availability must be confirmed directly with Dolphin Pharmaceuticals. Buyers should request confirmation of the product, manufacturer, documentation, quotation, and destination-market export eligibility.
5. What documents should I request from an apalutamide supplier?
Depending on the transaction, buyers may need product specifications, manufacturer information, batch documentation, a Certificate of Analysis where applicable, quality certificates, commercial invoices, packing lists, and relevant regulatory documents.
6. What storage conditions apply to apalutamide tablets?
Storage requirements depend on the exact product and its approved labeling. Buyers should obtain the manufacturer's current instructions and ensure that the shipment and receiving arrangements meet those requirements.
7. Can apalutamide be exported from India to any country?
No. Export and import eligibility depend on the specific product, the parties involved, and the regulations of the exporting and destination markets. Buyers must verify applicable approvals and permits before shipment.
8. What should buyers compare when evaluating quotations?
Compare product specifications, manufacturer, quantity, packaging, documentation, remaining shelf life, shipping arrangements, payment terms, and total procurement cost. Price alone should not determine supplier selection.
Conclusion
Exporting apalutamide 60 mg tablets from India requires careful attention to product quality, manufacturer transparency, documentation, storage requirements, commercial terms, and international regulatory compliance.
Dolphin Pharmaceuticals, based in Surat, Gujarat, India, can be contacted to discuss product-specific sourcing requirements. Current availability of apalutamide, the actual manufacturer, supporting documentation, and export eligibility must be confirmed directly before an order is placed.
For international pharmaceutical importers, distributors, and institutional procurement teams, a clear product specification and structured supplier assessment can support more informed sourcing decisions and help establish a transparent procurement process.
Contact Dolphin Pharmaceuticals with your required apalutamide 60 mg presentation, quantity, preferred manufacturer, and destination country to enquire about potential sourcing options and product-specific export requirements.
Disclaimer: This article is intended for pharmaceutical procurement and general informational purposes only. It does not provide medical advice or guarantee product availability, manufacturing status, regulatory approval, or export eligibility. Apalutamide should be used under the supervision of qualified healthcare professionals.
My Company Name - Dolphin Pharmaceuticals
My Website - https://www.dolphinpharma.in/